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The expression of the genes encoding the  three iso- 
forms of the human  ADP/ATP translocase (Tl,  T2,  and 
T3)  has been investigated in  cultured cell systems un- 
der different  experimental conditions, using isoform- 
specific probes. In  several human cell lines tested, i.e. 
HeLa, Hep3B, 143B, HL60, the  T3 gene is expressed 
as a single 1300-nucleotide mRNA, whereas the  T2 
gene produces two species of  mRNA, 1450 and 1600 
nucleotides in  size. These two species,  which are pres- 
ent in  HeLa  cells in approximately equivalent amounts, 
were shown to derive from the use of two different 
polyadenylation signals. The gene for  the muscle-spe- 
cific isoform of ADP/ATP translocase, T1, was not 
found to be expressed in any of the cell lines investi- 
gated. The levels of T2  and T3 mRNAs in HeLa cells 
are differentially affected by the  growth conditions. In 
fact,  the  T2 mRNA level remains  relatively constant 
throughout the exponential and stationary phases, 
whereas  the T3 mRNA level decreases progressively 
in the second  half of the exponential phase and in the 
stationary phase down  to less than 50%. This differ- 
ence in quantitative behavior of the two mRNAs must 
reflect changes in  their  rates of synthesis, since their 
half-lives are very  similar (tllz = 5-6 h),  with no sig- 
nificant growth-related differences. Treatment of 
HL60 cells with 12-0-tetradecanoylphorbol-13-ace- 
tate  or etinoic acid, two agents which induce cessation 
of cell proliferation and cell differentiation, resulted 
in a marked decrease in both T2  and T3 mRNA levels. 
Exposure of HeLa cells to chloramphenicol produced a 
pronounced decrease in the levels of both T2  and T3 
mRNAs after  48 to 72  h of treatment. Half-life time 
measurements strongly suggested that this decrease 
reflected a reduction in  the rate of synthesis of the two 
transcripts.  Treatment of HeLa cells with dinitrophe- 
nol also produced a dramatic decrease in the steady 
state levels of both T2  and T3 mRNA, which, however, 
in contrast to the  just mentioned situation, could  be 
accounted for by a decrease in  their metabolic stability. 
Control experiments indicated that  the chlorampheni- 
col- and dinitrophenol-induced changes were not a 
nonspecific  consequence of mitochondrial dysfunction. 
The observations reported here clearly demonstrate 
that the expression of the multiple ADP/ATP translo- 
case genes in human cells is sensitive to the cell  phys- 
iological conditions, responding to the  varying cellular 
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demands by changes in  the  rate of synthesis or  stability 
of their mRNAs. 
The adenine nucleotide translocase is a nuclear-encoded 
integral protein of the inner mitochondrial membrane (for 
reviews, see Vignais et al., 1985; Klingenberg, 1989). This 
enzyme, which is the most abundant protein  in mitochondria, 
exchanges ADP with ATP between the cytosol and  the mi- 
tochondrial matrix in  an electrogenic process (Laris, 1977). 
Such exchange, which links the compartment of ATP synthe- 
sis to those of ATP utilization, is essential for the aerobic 
energy metabolism of the cell. On the basis of amino acid 
sequence similarities observed with other mitochondrial 
translocators, the ADP/ATP translocase appears to be a 
member of a large mitochondrial carrier family. This includes 
the uncoupler binding protein (for review, see Klingenberg, 
1990), the phosphate  carrier (Runswick et al., 1987), and  the 
dicarboxylate and a-ketoglutarate-malate carriers (Bisaccia 
et al., 1988). 
Because of its  central role in  the cell energy metabolism, 
and because mitochondrial energy production varies among 
tissues, it is likely that the expression of the ADP/ATP 
translocase gene(s) is regulated in response to functional and 
developmental factors. The  first evidence of tissue-specificity 
of the bovine ADP/ATP translocase came from an analysis 
of the immunological reactivity of the translocase  extracted 
from different tissues (Schultheiss and Klingenberg, 1984). 
The existence of such isoforms has been confirmed in man 
using  a  different approach. In fact, the occurrence of at  least 
three different genes, TI, T2, and T3, coding for the human 
ADP/ATP translocase has been shown (Battini et aL, 1987; 
Neckelmann et al., 1987; Houldsworth and Attardi, 1988; 
Cozens et al., 1989; Li et al., 1989; Ku et al., 1990). The 
existence of multiple nuclear genes for the ADP/ATP trans- 
locase has also been reported in cow (Powell et al., 1989), 
Saccharomyces cereuisiae (Lawson and Douglas, 1988; Kolarov 
et al., 1990) and Zea mays (Bathgate et al., 1989). 
The results  reported in  this paper  demonstrate changes in 
the expression of the T2 and T3 genes in cultured human 
cells under  conditions which are expected to affect the cellular 
energy metabolism. In particular, changes in the levels or 
metabolic stabilities of the T2- and T3-specific mRNAs have 
been observed in response to growth conditions, differentia- 
tion  state of the cells, and mitochondrial inhibitors. 
EXPERIMENTAL PROCEDURES 
Cell Lines-HeLa S3 cells were grown in suspension as described 
(Amaldi and  Attardi, 1968). HL60 cells (Collins et al., 1977), grown 
in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal 
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Regulation of Expression of the  Multiple ADPIATP Translocase Genes 16535 
calf serum, were induced to differentiate by addition of 52 nM TPA’ 
or 1.25 mM RA. Other cell lines used in  this work include Hep 3B, 
derived from a human hepatocellular carcinoma (American Tissue 
Culture Collection CRL  HB8064), and 143B, derived from a human 
osteosarcoma (ATCC CRL 8303). 
RNA Isolation and Gel Blot Analysis-Total cellular RNA from 
tissues and various cell lines was extracted using  guanidinium  isothi- 
ocyanate (Chirgwin et al., 1979). Polyadenylated  RNA was isolated 
by double passage over an oligo(dT)-cellulose column (Amalric et al., 
1978) and fractionated by electrophoresis  through  a 1.4% agarose, 2.2 
M formaldehyde gel in  MOPS buffer (Davis et al., 1986). The RNA 
integrity in the samples before oligo(dT)-cellulose chromatography 
fractionation was verified by running a  portion of each  sample  on gel 
and checking the ratio of the two cytosolic rRNAs after ethidium 
bromide  staining.  RNA was transferred from the gels onto  Zeta-Probe 
membranes (Bio-Rad) by electroblotting. For  quantitative analysis, 
total RNA samples were applied by filtration onto a Zeta-Probe 
membrane using a Schleicher & Schuell Minifold I1 slot blotter 
apparatus. RNA on the membranes was fixed by baking for 2  h at  
80 “C in a vacuum oven, and the membranes were then washed, 
pretreated, and incubated for hybridization as described (Hould- 
sworth and Attardi, 1988), with some slight modifications. In  partic- 
ular, hybridization of cDNA-derived probes was carried out for 18 h 
a t  42 “C in the presence of 40% formamide (FA)  and 5 X SSC (1 X 
SSC is 150 mM NaCl,  15 mM sodium citrate, pH 7.0), hybridization 
of oligonucleotide probes  for 18 h a t  52 “C,  in  the absence of FA and 
in  the presence of 6 X SSC. 32P-Labeled probes were prepared by 
random  priming labeling (Feinberg and Vogelstein, 1983; Cobianchi 
and Wilson, 1987) (T2  and  T3 cDNA clone inserts,  GPDHase cDNA) 
or filling-in (T1 cDNA clone insert)  to a specific activity of  5-6 X lo8 
cprn/mg, or by 5’-end labeling of purified synthetic oligonucleotides 
with T4 polynucleotide kinase and  [Y-~’P]ATP. After hybridization 
with the different labeled probes (4 X lo6 to 2 X lo7 cpm), the filters 
were processed as described previously (Houldsworth and Attardi, 
1988). 
Southern Blot Analysis-Total DNA was extracted from HeLa 
cells by the method of Hermann  and Frischauf (1987) and digested 
with restriction endonucleases in  the buffers recommended by the 
suppliers. The digested DNA was fractionated on a 0.8% agarose gel 
in 50 mM Tris-borate, 1 mM EDTA, and,  after  denaturation in 0.5 M 
NaOH, 1.5 M NaCI, it was transferred by capillarity onto a Zeta- 
Probe membrane in 1 M ammonium acetate, 20 mM NaOH overnight 
(Southern, 1975; Rigaud et al., 1987). Hybridization of the DNA to 
the different labeled cDNA probes (1.0-1.7 X lo7 cpm) was carried 
out  at 42 ‘C in 40% FA, 5 X SSC, 0.1% sodium dodecyl sulfate, 1 X 
Denhardt’s  solution (1 X Denhardt’s  solution  is 0.02% Ficoll, 0.02% 
polyvinylpyrrolidone, 0.02% bovine serum  albumin), 20 mM sodium 
pyrophosphate,  10% dextran sulfate, and 0.01% salmon  sperm DNA. 
DNA Probes-A specific cDNA probe for T1 was subcloned by 
digestion of the clone pHAT 14  (Houldsworth and Attardi, 1988) with 
NciI (Fig. l ) ,  filling-in the  ends of the fragment, and ligating it  into 
the Hind11 site of the polylinker of pUC9. After digestion of the 
recombinant pUC9 derivative with BarnHI and EcoRI, the  insert was 
isolated by electrophoresis in a sodium dodecyl sulfate-polyacryl- 
amide gel. T2-  and T3-specific cDNA probes were obtained by diges- 
tion, respectively, of the clone pHAT 8 with Ban11 and of the clone 
pHAT 3 with HindIII + MaeIII,  and isolation of the fragments by 
agarose gel electrophoresis. Two oligonucleotides complementary to 
the coding strand of the T1 gene were synthesized T1-1 (nt 1204- 
1228) and T1-2 (nt 3-27). The T1-1 probe exhibits about 13% 
sequence similarity to  the corresponding T2  and  T3 segments, 
whereas the T1-2 probe has 42% and, respectively, 50% similarity to 
the corresponding T2  and T3  sequences. The nucleotide numbering 
in  the cDNA probes and oligonucleotides used in  the  present work 
corresponds to that used for the cDNA sequences, as previously 
reported (Houldsworth and Attardi, 1988). The glyceraldehyde-3- 
phosphate dehydrogenase (GPDHase) probe was a full-length rat 
cDNA clone (Fort et al., 1985) (kindly provided by Dr. Ph.  Jeanteur). 
RESULTS 
ADPIATP Translocase Gene-specific  Probes-To facilitate 
a comparison between the various data in the literature, we 
’ The abbreviations used are: TPA, 12-O-tetradecanoylphorbol-13- 
acetate; RA, retinoic acid; GPDHase, glyceraldehyde-3-phosphate- 
dehydrogenase; CAP, chloramphenicol; FA, formamide; nt, nucleo- 
tide; MOPS, 4-morpholinepropanesulfonic acid. 
will use the following terminology: T1 will  be  used to refer to 
the  ANT1 gene (Li et al., 1989), the T1 gene (Cozens et al., 
1989) and  the pHAT14 partial cDNA clone (Houldsworth and 
Attardi, 1988). T2 will be used to refer to  the T2 gene (Cozens 
et al., 1989) and  to  the  pHAT8  partial cDNA clone (Hould- 
sworth and Attardi, 1988). T3 will be used to refer to the 
hp2Fl cDNA clone (Battini et al., 1987), designated as ANT2 
by other  authors (Li et al., 1989), and to the pHAT3  partial 
cDNA clone (Houldsworth and Attardi, 1988). In order to 
achieve a high selectivity in  the analysis of the HeLa cells 
mRNAs and  in  the  Southern blot analysis, three cDNA probes 
corresponding to segments of the pHAT14, pHAT8, and 
pHAT3  partial cDNA clones (Houldsworth and Attardi, 1988) 
were isolated. The specific probes, shown in Fig. 1, were 
characterized by a relatively low degree of nucleotide sequence 
similarity (see legend). Specific oligonucleotides correspond- 
ing to selected regions of the cDNAs were also synthesized 
(see below). 
Number of Genes for the ADP/ATP Translocase-Southern 
blot hybridization experiments were carried out on digests of 
total HeLa cell DNA obtained with three restriction enzymes 
(EcoRI, BamHI,  and  HindIII). On the basis of the published 
cDNA sequences (Battini  et al.,  1987; Neckelmann et al.,  1987; 
Cozens et al., 1989), these enzymes were not expected to  cut 
the portions of the cDNA sequences used as probes. Further- 
more, on the basis of the genomic sequences (Cozens et al., 
1989; Ku et al., 1990), the various cDNA probes did not 
overlap adjacent exons. As shown in Fig. 2, in all digests, the 
presence of only one  band  reacting with a T1-specific probe 
and of at least two bands reacting with a T2-specific probe 
was detected. On the  other hand,  experiments conducted with 
a specific probe derived from the  T3 cDNA revealed a much 
greater complexity of the  Southern blot hybridization pattern. 
These  results are consistent with there being a single gene 
and no pseudogene for T1, one or two genes for T2, and 
several genes for T3, possibly including pseudogenes. 
Identification of the mRNA Species Expressed in HeLa 
Cells-A previous analysis of the ADP/ATP translocase 
mRNAs expressed in  HeLa cells had revealed three discrete 
mRNA species, with sizes of 1300,  1450 and 1600 nt, respec- 
tively (Houldsworth and Attardi, 1988). The  authors reported 
that  the T2 cDNA probe used (pHAT8) reacted with all three 
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FIG. 1. Isoform-specific probes derived from the ADP/ATP 
translocase cDNAs. The probes were isolated as described under 
“Experimental Procedures.” Probe TI ,  which is 124 nt long, contains 
a 101-nt fragment (-58 to +42) of the cDNA generated by NciI 
digestion. This fragment  overlaps  a  portion f the 5’-noncoding region 
and the first 42 coding nucleotides in exon 1 of the T1 gene, and 
shows 51% and, respectively, 52% sequence similarity to  the corre- 
sponding segments of T2  and T3. Probe 2’2, which is 259 nt long, 
overlaps the last 13 coding nucleotides and a portion of the 3’- 
noncoding sequence in exon 4 of the  T2 gene, and shows 16% and, 
respectively, 14% sequence similarity to  the corresponding stretches 
of T1 and T3.  Probe 2‘3, which is 304 nt long, overlaps the  last 91 
coding nucleotides and a  portion of the 3”noncoding sequence of the 
T3  gene, and shows 41% and, respectively, 39% sequence similarity 
to  the corresponding  segments of T1 and T2. 
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FIG. 2. Hybridization of  digests  of human DNA with probes 
derived from human ADP/ATP translocase cDNAs. The spe- 
cific hybridization probes illustrated in Fig. 1 were  employed. HeLa 
S3 total DNA  was digested with the following restriction endonucle- 
ases. a, BamHI; b, EcoRI; c, HindIII. The digests were fractionated 
in a 0.8% agarose gel, transferred onto a Zeta-Probe membrane, and 
hybridized with the specific R‘P-labeled probes, as detailed under 
“Experimental Procedures.” Size markers correspond to fragments of 
bacteriophage lambda DNA generated by  Hind111 digestion. 
species, the most strongly hybridizing species being the 1450- 
n t  mRNA. The T1 cDNA probe  (pHAT14) hybridized only 
very weakly with the 1300-nt mRNA species; on the  contrary 
the  T3 cDNA probe (pHAT3) gave a strong signal with this 
mRNA, and only a marginal reaction with the other two 
mRNA species. The cross-hybridization observed between the 
three mRNA species resulted from the high nucleotide se- 
quence similarity existing between the T1, T2,  and  T3 se- 
quences, especially in the protein coding sequence (Cozens et 
al., 1989). 
An RNA transfer hybridization analysis of HeLa cell 
mRNA carried out under the conditions described under 
“Experimental Procedures” showed no hybridization with the 
T1-specific probe (Fig. 3). This also held true under  conditions 
of hybridization and washing of much lower stringency. Sim- 
ilarly, no hybridization of the T1 probes (cDNA fragment and 
T1-1 and  TI-2 oligonucleotides) was detected  with the 
mRNA from the  other cell lines tested, i.e. Hep 3B, 143B, and 
HL60. In all  human cell lines used in  this work, the specific 
T2 probe hybridized strongly with the two larger mRNA 
species (1450 and 1600 nt), whereas the T3-specific probe 
reacted only with the  shorter mRNA species (1300 nt). 
Two Polyadenyhtwn Signals Are Used during Transcription 
of the T2 Gene in HeLa Cells-In their analysis of the sequence 
of the T2 gene, Cozens et al. (1989) described the presence of 
a typical polyadenylation signal AATAAA located 428 nt  after 
the  stop codon and 15 nt  upstream of the polyadenylation site 
in  the homologous bovine gene. On the  other  hand, Hould- 
sworth and Attardi (1988) reported the presence of a poly(A) 
tail  starting 326 nt  after  the  stop codon in  their cDNA clone 
corresponding to  the  T2 gene (pHAT8). No typical polyade- 
nylation signal was found upstream of this poly(A) tail. To 
investigate the possibility that  the 1450- and 1600-nt mRNAs 
hybridizable with the  T2 probe reflected the processing of the 
mRNA precursors at  the two polyadenylation sites identified 
by the above cited  authors, two oligonucleotides complemen- 
tary  to mRNA sequences located, respectively, 21-nt 5‘ to  the 
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FIG. 3. RNA transfer hybridization analysis of HeLa cell 
mRNA. Polyadenylated mRNA was isolated from exponentially 
growing HeLa cells, fractionated by electrophoresis in a 1.4%  agarose, 
2.2 M formaldehyde gel (4 pgllane), electroblotted onto  a Zeta-Probe 
membrane, and hybridized with the specific ”P-labeled probes, as 
described under “Experimental Procedures” (TI, 5 X lo6 cpm, 36 h 
exposure; T2, 4 X lo6 cpm, 24 h exposure; T3, 6 X lo6 cpm, 24 h 
exposure). Mitochondrial RNA species labeled in isolated organelles 
(Gaines and Attardi, 1984) were used as molecular weight markers 
(lane M). The sizes of 16 S rRNA, RNA 11,12 S* rRNA, and 12 S 
rRNA are 1559,  1200,  1045, and 954 nt, respectively. 
upstream poly(A) tail (T2-1: 5’ CACGACTTGGCTCCTA- 
CAAGCA), and 15-nt 5‘ to  the canonical AATAAA signal 
(T2-2:  5’  GCCCAACATAGAACATACTC),  were synthesized 
(Fig. 4). RNA transfer hybridization analysis of HeLa cell 
mRNA was performed using the two oligonucleotides as 
probes. Fig. 4 shows clearly that only T2-1 probe was able to 
hybridize with the two mRNA species, whereas T2-2 probe 
could only detect the longer mRNA species. Similar  results 
were obtained with the mRNA from other cellular systems, 
in particular the Hep 3B, 143B, and HL60 cell lines and 
cultured human myoblasts (not shown). These  results 
strongly suggest that  the two mRNA species derive indeed 
from the use of the canonical AATAAA signal and of an 
alternate nontypical signal upstream of nt 326, possibly ATT- 
TAAA (Swimmer and Shenk, 1985). When cells were  grown 
under normal conditions, both polyadenylation signals ap- 
peared to be used with the same efficiency, as judged from the 
results of the RNA transfer hybridization experiments. On 
the contrary, when HeLa cells were  grown in  the presence of 
0.2 mM oligomycin, an inhibitor of the mitochondrial H’- 
ATPase, the steady state amount of the  shorter mRNA species 
was significantly higher than  that of the species using the 
typical polyadenylation signal. The physiological significance 
of this observation remains, however, unknown. 
The T2 and T3 Genes Are  Differentially Expressed at Dif- 
ferent  Phases of HeLa Cell Growth-The T3 gene expressed 
in HL60 cells has been reported to be a growth-regulated gene 
(Battini et al., 1987). However, in the  just cited work, a whole 
T3 cDNA probe, not  apt  to distinguish between mRNAs for 
different isoforms of the translocase, was used. In  the present 
work, the hypothesis that synthesis or stability of the different 
ADP/ATP translocase mRNAs expressed in HeLa cells may 
depend upon the growth-phase was tested. The level of the 
different mRNAs was estimated either  after  transfer hybrid- 
ization or  after slot-blot hybridization of the  total RNA sam- 
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FIG. 4. RNA transfer hybridization analysis of the T2-spe- 
cific mRNAs. Total RNA (12 pg) from exponentially growing HeLa 
cells was fractionated  on  a formaldehyde/agarose gel and electroblot- 
ted  onto a  Zeta-Probe  membrane. The filters were incubated  with the 
'"P-labeled T2-specific cDNA probe and  the '*P-labeled T2-specific 
oligonucleotides T2-1 and T2-2, complementary to the indicated 
sequences, as detailed under "Experimental  Procedures" (T2 ,4  X lofi 
cpm, 36 h exposure; T2-I, 2 X lo7 cpm, 48 h exposure; T2-2, 1.7 X 
10' cpm, 48 h exposure). M, HeLa cell mitochondrial  RNAs labeled 
in isolated organelles (see Fig. 3). 
ples  extracted from HeLa cells harvested at  different  stages 
of growth. Fig. 5 shows that the level of the T2 mRNA 
remained relatively constant throughout the exponential and 
the early and  late  stationary phases. By contrast,  the level of 
the  T3 mRNA decreased as  the cell culture  approached and 
reached the stationary phase, down to less than 50%. A 
significant decrease was already observed in the  late portion 
of the exponential phase. Ethidium bromide staining of the 
different RNA preparations  indicated that  the differences in 
the ADP/ATP  translocase mRNA levels were not  the conse- 
quence of a differential degradation of the RNA samples. 
To address the possibility that  the level of expression of 
the T2 and  T3 genes is regulated a t  a posttranscriptional 
level, the stability of T2 and  T3  transcripts  in  the exponential 
and stationary  phases of growth was investigated. For this 
purpose, DNA transcription was blocked with actinomycin D 
in HeLa cells at  different  stages of growth, and  the  amount 
of  mRNA surviving after various times of drug treatment was 
measured by hybridizing cDNA probes labeled by random 
priming to fixed amounts of total cell RNA slot-blotted onto 
a Zeta-Probe membrane. As shown in Table I, the  T2  and  T3 
gene-specific transcripts have almost  identical half-lives (re- 
spectively, 6 and 5 h), pointing to a regulation of expression 
of these genes at  the transcriptional level. Furthermore, for 
both genes, no significant difference in the half-life of the 
mRNAs extracted from cells in the exponential and  stationary 
phases of growth could be detected. 
T2 and T3 Gene Expression Is Affected by the Differentiation 
State of HL60 Cells"HL60 cells are a human promyelocytic 
leukemia cell line  in which the promyelocyte can  be induced 
to differentiate by treatment with various agents (for review, 
Koeffer, 1983). TPA induces terminal differentiation  in  HL60 
along the monocyte-macrophage pathway, whereas RA in- 
duces differentiation along the granulocyte pathway. In a 
, .o' 
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FIG. 5. Analysis of the ADP/ATP translocase mRNA species 
expressed at different stages of HeLa cell growth. Samples (12 
pg) of total RNA extracted from HeLa cell suspensions  harvested at  
the indicated times were applied by filtration onto Zeta-Probe mem- 
branes, using a slot-blotter apparatus. The membranes were incu- 
bated  with the "P-labeled T2-specific (A) and T3-specific (W) cDNA- 
derived probes, as described under  "Experimental Procedures." The 
mRNAs were quantitated by densitometric  scanning of the autora- 
diograms. Cell growth was estimated by measuring the cell concen- 
tration in a parallel culture at the indicated times (0). An RNA 
transfer hybridization  analysis of the  total RNA samples, performed 
with T1-, T2-, and T3-specific probes, showed lack of any sign of 
degradation of the  T2  and  T3 translocase  mRNAs and absence of the 
T1 mRNA. 
TABLE I 
Half-lives of the ADPIATP translocase T2  and T3 mRNAs at 
different stages of HeLa cell growth and 
in the presence of CAP and DNP 
Exponentially growing HeLa cells (6 X lo5 cells/ml), stationary 
phase cells (1.2 X 10' cells/ml) and cells grown in presence of CAP 
or  DNP,  as indicated, were treated with  5 pg/ml actinomycin D. After 
various times of exposure to  the  latter drug, cells were collected, total 
RNA was extracted, and identical amounts (12 pg) of RNA from the 
different samples were subjected to slot blot hybridization, as de- 
scribed under "Experimental Procedures." Zero time of actinomycin 
D treatment was used as a reference for the initial mRNA content. 
Growth conditions 
t% 
T2 T3 
h 
No drug 
Exponential  phase 6 5 
Stationary phase 6  5 
CAP 40 pg/ml, 3 days 6 6.5 
DNP 200 ptM, 12  h 1.5 2 
previously cited work (Battini  et al., 1987), a decrease in the 
level of ADP/ATP  translocase  mRNA(s) hybridizable with a 
non-isoform-specific whole T3 cDNA probe was reported in 
HL60 cells induced to differentiate by either TPA or RA. It 
seemed interesting to re-examine this phenomenon using 
isoform-specific probes. Therefore, exponentially growing 
HL60 cells were treated  either with 52 nM TPA or 1.25 mM 
RA for 72 h. Cytoplasmic RNA was extracted and electro- 
transferred, and the RNA blots were hybridized with the 
T1-, T2-, and T3-specific probes. As shown in Fig. 6, both 
TPA  and RA caused a marked decrease in  the level of both 
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FIG. 6. Levels of ADP/ATP translocase mRNAs in HL60 
cells after  treatment  with TPA and RA. Suspensions of expo- 
nentially growing HL60 cells (4 X IO”/ml)  were either  treated  with 
52 nM TPA  or with 1.25 mM RA, or  maintained  untreated  as  control 
(CTL). The cells were harvested  after 72 h, total  RNA was extracted, 
and 11 pg samples were run  on  an agarose/formaldehyde gel, trans- 
ferred  onto  Zeta-Probe  membranes  and hybridized with R“P-labeled 
T2-specific and T3-specific  cDNA-derived  probes, as described under 
“Experimental Procedures.” M, mitochondrial  RNA species labeled 
in isolated  organelles (see Fig. 3). 
T2 and  T3 mRNAs after 72 h of exposure of the cells to  these 
agents.  A  quantitative  analysis showed that  the  T2  and  T3 
mRNA levels in TPA-treated cells had decreased to 40% of 
those in  non-treated HL60 cells (CTL), whereas the levels of 
T2 and  T3 mRNAs in RA-treated cells ranged between 55 
and 65% of the control levels.  No mRNA species correspond- 
ing to  the T1 gene was detected in HL60 cells under these 
differentiating conditions. 
ADPIATP Tramlocase Gene Expression Is Affected  by the 
Physiological State of the Mitochondria-Expression of some 
nuclear genes encoding mitochondrial proteins is known to 
be regulated according to the growth conditions and the 
metabolic demands of the cell (Guarente and Mason, 1983; 
Szekely and Montgomery, 1984; Parikh  et al., 1987; Attardi 
and Schatz, 1988). Since the ADP/ATP translocase is a 
protein which plays a major role in  the energy metabolism of 
the cell linked to respiration, the effects of chloramphenicol 
(CAP) and dinitrophenol (DNP), two drugs which affect, 
respectively, the biosynthetic and energy yielding processes 
of the organelles, were tested. 
HeLa cells were exposed to a  concentration of CAP (40 pg/ 
ml) which is sufficient to inhibit  mitochondrial  protein  syn- 
thesis. It was previously found that, under  these conditions, 
cells grew at a normal rate for two doublings, with only a 
slight decrease in cell size, and then entered a stationary 
phase, as contrasted to control cells which continued to grow 
for at  least five doublings (Storrie and Attardi, 1972). Cells 
grown in the presence of CAP were harvested at  different 
times, and  the  amounts of the different ADP/ATP translocase 
mRNAs were measured. In Fig. 7, the T2 and T3 mRNA 
levels in  CAP-treated cells are compared to  those  in control 
cells grown under the same  conditions except for the absence 
of CAP. In agreement with the observations reported above, 
in  the control cultures, the T2 mRNA level remained approx- 
imately constant for more than 4 days, relative to  total cell 
RNA, whereas the  T3 mRNA level declined to  about 50%. By 
contrast, in the CAP-treated cells, the  amount of T2  and  T3 
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FIG. 7. Effect of CAP on the expression of the ADP/ATP 
translocase genes in HeLa cells. 400 ml of HeLa cell suspension 
cultures (2 X 105  cells/ml)  were  exposed to 40 pg/ml CAP and 
harvested at   the  indicated  times. Parallel  HeLa cell cultures, grown 
under  the  same  conditions  except for the  absence of CAP, were used 
as controls. Samples  (12 pg) of total  RNA  extracted from the various 
cultures were slot-blotted  onto  Zeta-Probe  membranes,  and  the mem- 
branes were then  incubated with a 32P-labeled  T2-specific (A, A), T3- 
specific (0, W) or GPDHase-specific (0,O) cDNA-derived  probe, as 
described under  “Experimental Procedures.” The mRNAs  extracted 
from CAP-treated cells (A, W, 0) and  those  extracted from control 
cells (A, 0, 0) were quantitated by densitometric scanning of the 
autoradiograms. 
mRNA remained stable for 3 and, respectively, 2 days, and 
then dropped sharply  during the following days. It  has previ- 
ously been shown that CAP, at  the concentration used in the 
present  experiments, does not affect nuclear RNA synthesis 
for at  least  3  days (Storrie  and Attardi, 1972). Furthermore, 
in the present work, the total RNA content/cell did not 
decline after 3  days of CAP treatment relative to  the control 
value, and decreased by only 30% in the fourth day. Therefore, 
the present data indicate an actual decrease in the levels of 
T2  and  T3 mRNA/cell during  CAP treatment.  The half-lives 
of the T2 and  T3 mRNAs surviving after 3 days of CAP 
treatment, determined in  the presence of actinomycin D, did 
not reveal any significant change in the stability of the ADP/ 
ATP mRNAs in  the presence of CAP (Table I). 
As a  control for the specificity of the CAP effects on the 
T2 and  T3 mRNA levels, the relative amounts of mRNA for 
a  non-mitochondrial housekeeping enzyme, GPDHase, were 
measured in control cells and in  CAP-treated cells. To  this 
end,  a rat cDNA for GPDHase was used for slot-blot hybrid- 
izations, by taking advantage of the high degree of nucleotide 
sequence conservation found in both coding and 5’- and 3’- 
noncoding regions between rat  and human  GPDHase cDNAs 
(Fort  et al., 1985). The  rat GPDHase cDNA probe detected 
in human cell RNA samples an mRNA species -1400 nt in 
size, in agreement  with previously reported observations 
(Dani et al., 1984). As shown in Fig. 7, the relative levels of 
GDPHase remained constant for 4 days in  control cells, and 
declined only very slightly (about 10% after  4 days) in CAP- 
treated cells. 
Exposure of HeLa cells to  DNP, a drug which acts as a 
potent uncoupler of oxidative phosphorylation, altering  dra- 
matically the aerobic process of ATP synthesis, resulted in a 
rapid decrease of the levels of the ADP/ATP translocase 
mRNAs (Fig. 8). After 24 h of exposure to  DNP,  the relative 
amounts of T2 and  T3 mRNA were 13% and, respectively, 
6% of the original value. The half-lives of T2  and  T3 mRNAs, 
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FIG. 8. Effect of DNP on the expression of the ADP/ATP 
translocase genes in HeLa cells. Two HeLa cell suspension cul- 
tures (4 X lo5 cells/ml) were  grown in  the presence or absence of 200 
mM DNP,  and aliquots (200 pl) were harvested at  the indicated times. 
Samples of total RNA extracted from the various aliquots were 
analyzed as detailed in the legend for Fig. 7. A, U, 0 DNP-treated 
cells; A, 0,O control cells grown in  the absence of DNP. 
estimated  in the presence of actinomycin D in cells previously 
exposed for 12  h to  DNP, were much lower than those  found 
in control cells grown under the same conditions except for 
the absence of DNP (Table I). Fig. 8 shows that,  in  contrast 
to  the T2 and  T3 mRNAs, the GPDHase mRNA was only 
moderately affected by DNP  treatment, its relative level being 
still 90% of the control value after 12 h and >60% after 24 h. 
DISCUSSION 
The physiological significance of the existence of tissue- 
specific isoforms of ADP/ATP translocase is probably related 
to  the different functional  properties of these isoforms, which 
result from their  structural differences. It is a plausible hy- 
pothesis that differences in  the regulatory properties of the 
ADP/ATP translocase and  in  its responses to  the membrane 
potential and  the ADP/ATP  ratio play an essential role in 
satisfying  organ- or cell-specific energetic requirements.  Con- 
sistent with this hypothesis is the main conclusion of the 
present  study, namely, that  the expression of the genes con- 
trolling the isoforms of the ADP/ATP  translocase is sensitive 
to  the cell metabolic and energetic state  and  that hese genes 
respond either differentially or coordinately to growth condi- 
tions, tissue-specific factors, and metabolic inhibitors. 
Hybridization experiments  carried out with restriction  di- 
gests of human DNA using cDNA and oligonucleotide probes 
highly specific for each of the  three translocase cDNAs have 
indicated the presence in  the genome of only one TI-related 
sequence and two or several T2-related sequences; some of 
the  latter may correspond to pseudogenes (Cozens et al., 1989). 
Interestingly, hybridization experiments conducted with a T3- 
specific probe have shown the presence of numerous  different 
sequences related to  the  T3 cDNA. A possible explanation for 
the multiplicity of sequences related to  T3 in  man would  be 
the presence of a family of T3-related genes. It is relevant to 
mention,  in this connection, that, in order to account for some 
specific metabolic pathways, it has been suggested that  an 
ADP/ATP translocase may be located in other intracellular 
organelles besides mitochondria (West  and Clegg,  1984; Ko- 
larov et al., 1990). On the  other hand, the occurrence of several 
T3-related pseudogenes in the  human genome has been re- 
cently reported (Chen et al., 1990). 
Despite the use of conditions of  low stringency hybridiza- 
tion, probes specific for the muscle isoform of the translocase, 
T1, did not  react with the mRNAs extracted from HeLa S3, 
HL60, Hep 3B, or 143B cells. It should be mentioned, how- 
ever, that the presence of an mRNA reacting with a T1- 
specific probe has been reported in HeLa cells (Li et al., 1989). 
The reason for this discrepancy is not known. However, the 
possibility that  the T1-specific probes failed, under the con- 
ditions used here, to hybridize with T1 transcripts could be 
ruled out, since, in parallel experiments, mRNA extracted 
from human muscle  gave a  strong signal with both the oligo- 
nucleotide and cDNA T1-specific probes.' The muscle-specific 
T1 mRNA species detected in the  last cited experiments had 
a size of 1400 nt,  in agreement with a previous report  (Neck- 
elmann et al., 1987) and with gene sequence data (Cozens et 
al., 1989). 
The observation that  the steady state level of T3 mRNA 
decreased progressively during prolonged growth of HeLa cells 
is consistent with a previous report (Battini et al., 1987) 
indicating that  the  T3 mRNA level in Balb/c/3T3 cells is 
sensitive to growth factors. On the  other hand, the relatively 
constant level of T2 mRNA throughout the exponential and 
stationary phases of growth points to a regulation of T2 gene 
expression different from that of the  T3 gene. The evidence 
obtained in  the present work indicates that  this difference in 
regulation occurs at  the transcriptional level. 
The marked decrease in the levels of both T2 and T3 
mRNAs observed in  HL60 cells treated with TPA or RA is at  
variance with the phenomenon observed during prolonged 
culture of HeLa cells, in which the decrease affected mainly 
the  T3 mRNA. In  the case of HL60 cells treated with TPA, 
the decline in the level of the  ADP/ATP translocase mRNAs 
is intriguing, since differentiation along the monocytic-mac- 
rophage pathway has been reported to be accompanied by an 
increase in  the  amount of the mitochondrial profiles in TPA- 
treated cells (Rovera et al., 1979). 
The results  obtained  in the present work on the effects of 
CAP, an inhibitor of mitochondrial protein synthesis, and 
DNP, a potent uncoupler of mitochondrial oxydative-phos- 
phorylation, clearly illustrate how responsive the expression 
of the ADP-ATP translocase genes is to the physiological 
state of mitochondria. Previous studies on the response of 
nuclear genes encoding mitochondrial proteins to inhibitors 
of mitochondrial function have revealed differences in behav- 
ior of different genes. Thus,  treatment of wild-type Neuro- 
spora cells with  CAP  has been shown to result  in increased 
synthesis of a  number of different mitochondrial constituents 
encoded by nuclear genes, including mitochondrial ribosomal 
proteins, cytochrome c, alternative oxidase, and possibly mi- 
tochondrial RNA polymerase (Kuiper et d., 1988). An in- 
crease in  the abundance of several nuclear DNA transcripts 
relative to  the wild-type levels has been observed in isochro- 
mosomal respiratory-deficient yeast stains, including p a  pe- 
tites  (Parikh et al., 1987). Similarly, an increase in the expres- 
sion of the  T3 ADP/ATP  translocase gene has been detected 
in the po derivatives of the human 143B cell line, which lack 
mitochondrial  protein  synthesis due to  the absence of mito- 
chondrial DNA (King  and Attardi, 1989).' The observations 
discussed above are  consistent with the suggestion that  the 
increase in the level of expression of some nuclear genes 
encoding mitochondrial proteins may be part of a general 
cellular response to impaired mitochondrial functions  (Kuiper 
et al., 1988). However, there is also clear evidence that  the 
expression of other nuclear genes for mitochondrial proteins 
is decreased under the same conditions (Parikh et al., 1987). 
The data reported in this paper indicate that  the ADP/ 
* J. Lunardi and G .  Attardi, unpublished observations. 
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ATP translocase genes belong to  the  latter class of genes. In 
fact,  both  after CAP or  DNP  treatment, we observed a de- 
crease  in the levels of T2 and  T3 mRNAs. A comparison with 
the behavior of the mRNA for a  non-mitochondrial house- 
keeping enzyme, GPDHase, showed that  the observed effects 
of these inhibitors on T2 and  T3 gene expression are not 
simply the consequence of the cell loss of energy producing 
capacity, but probably reflect specific phenomena. In  the case 
of the CAP treatment, half-life measurements clearly showed 
that the decrease in T2 and T3 mRNA levels reflected a 
reduction in  their  rates of synthesis. The fact that  this reduc- 
tion occurred only after 2 to 3 days of cell culture in the 
presence of CAP has possibly the same basis as  the delay in 
inhibition of cell growth observed under the same conditions. 
Storrie  and Attardi (1972) interpreted this delay as reflecting 
the time required for the pre-existing  respiratory  capacity of 
the cell to decrease, due to cessation of assembly of respiratory 
enzymes, to  the point of becoming rate-limiting. Similarly, 
one could speculate that  ADP/ATP translocase gene expres- 
sion is not affected until  the impairing of the mitochondrial 
respiratory function, resulting from inhibition of the mito- 
chondrial  protein  synthesis, reaches a  certain  threshold level. 
The observed effects of DNP  treatment on  translocase gene 
expression were quite different from those of CAP treatment, 
since 6-13%  of the relative amounts of the  ADP/ATP  trans- 
locase mRNAs present  in  control cells could be measured in 
cells treated with 200 mM DNP for 24 h. Furthermore, this 
decrease in the steady state levels of the translocase mRNAs 
could well be accounted for by their increased metabolic 
instability. In  the presence of DNP,  the inner mitochondrial 
membrane becomes permeable to H+, and both the  pH gra- 
dient  and  the membrane potential are destroyed. The presence 
of DNP in the culture medium should block the import of the 
ADP/ATP translocase into mitochondria, since this process 
requires a high membrane potential. An intriguing possibility 
is  that  the increased instability of the T2 and  T3 ADP/ATP 
translocase mRNAs is related to the accumulation of the 
protein  in the cytosol, reflecting an autoregulation phenome- 
non similar to  that operating  in the control of tubulin mRNA 
stability (Cleveland, 1988). 
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